Introduction
Nigeria has the highest burden of sickle cell disease of any country in the world. Approximately 150,000 Nigerian children are born with sickle cell disease every year more than 400 children every single day.
Yet despite these staggering numbers, awareness, understanding, and access to proper care remain inadequate across the country, particularly in northern states like Gombe.
This guide is designed to give every Nigerian adult a clear, honest, and practical understanding of sickle cell disease what it is, who is at risk, what the symptoms look like, how it is managed, and most importantly, what every couple should know before starting a family.
What is Sickle Cell Disease?
Sickle cell disease is a group of inherited blood disorders that affect the shape and function of red blood cells.
In a healthy person, red blood cells are round and flexible, allowing them to move easily through blood vessels and carry oxygen efficiently.
In a person with sickle cell disease, a genetic mutation causes red blood cells to become hard, sticky, and crescent-shaped. These cells cannot move freely. They get stuck, clump together, and block blood flow.
When blood flow is blocked, tissues and organs are deprived of oxygen causing severe pain, organ damage, and potentially life-threatening complications.
Sickle cells also die much faster than normal red blood cells about 10–20 days compared to 120 days leading to chronic anaemia.
Understanding Genotypes: The Foundation of Sickle Cell
Every person inherits two haemoglobin genes one from each parent. These determine your genotype:
- AA — Normal haemoglobin
- AS — Carrier (usually healthy but can pass the gene)
- SS — Sickle cell disease
- AC — Haemoglobin C trait
- SC — A form of sickle cell disease that is often milder than SS, but can still cause serious complications
When Two AS Parents Have Children:
- 25% → AA
- 50% → AS
- 25% → SS
👉 Each pregnancy carries a 1 in 4 risk of sickle cell disease.
Symptoms of Sickle Cell Disease
Sickle cell disease affects nearly every organ system.
Pain Crises
The most common and severe symptom.
Triggered by:
- Dehydration
- Cold
- Infection
- Stress
- Overexertion
Anaemia
- Fatigue
- Weakness
- Jaundice
- Shortness of breath
Infections
Due to damage to the spleen, patients are highly vulnerable.
👉 This is why preventive antibiotics in early childhood and full immunisation are essential.
Stroke
Sickle cell disease is one of the leading causes of stroke in children.
Early monitoring is critical.
Acute Chest Syndrome
A life-threatening lung complication.
👉 Medical emergency
Other Complications
- Delayed growth
- Leg ulcers
- Eye damage
- Kidney disease
- Priapism
How is Sickle Cell Disease Managed?
There is currently no widely accessible cure in Nigeria, although bone marrow transplant can cure selected patients.
Key Management Strategies
-
Hydroxyurea
Reduces pain crises, complications, and improves survival -
Folic acid supplementation
Supports red blood cell production -
Preventive antibiotics (children)
Protect against life-threatening infections -
Adequate hydration
Essential daily habit -
Avoiding triggers
Cold, stress, dehydration - Regular medical follow-up
-
Immunisations
All routine vaccines plus additional protection against infections such as pneumococcal and meningococcal disease -
Blood transfusions
For severe complications
The Critical Importance of Genotype Testing
Every Nigerian adult should know their genotype.
This is essential for:
- Marriage decisions
- Family planning
If both partners are carriers (AS) or have abnormal genotypes, there is a significant risk of having a child with sickle cell disease.
👉 Informed decisions require testing and counselling.
At Amkamed Pharmaceuticals, Gombe State, we guide you on where to access reliable genotype testing.
What Every Parent of a Sickle Cell Child Should Know
- Start care early
- Never miss medications
- Fever ≥38.5°C = emergency
- Maintain hydration
- Inform school
- Join support groups
Conclusion
Sickle cell disease is Nigeria’s most common genetic condition — and one of the most preventable causes of suffering through informed reproductive decisions.
With proper knowledge and consistent care:
- Couples can make informed choices
- Children can be diagnosed early
- Patients can live longer, healthier lives
Know your genotype. Test early. Manage consistently.
At Amkamed Pharmaceuticals, Gombe State, our pharmacists are here to guide you on testing, medication, and access to specialist care.
Know your genotype. Protect your future children.
Visit Amkamed Pharmaceuticals, Gombe State for trusted guidance.
References
Feasibility and Acceptability of Early Infant Screening for Sickle Cell Disease in Lagos, Nigeria-a Pilot Study.PloS One. 2020. Oluwole EO, Adeyemo TA, Osanyin GE, et al.
Sickle Cell Disease: A Review.The Journal of the American Medical Association. 2022. Kavanagh PL, Fasipe TA, Wun T.
Child Mortality From Sickle Cell Disease in Nigeria: A Model-Estimated, Population-Level Analysis of Data From the 2018 Demographic and Health Survey.The Lancet. Haematology. 2021. Nnodu OE, Oron AP, Sopekan A, et al.
Sickle Cell Disease in Sub-Saharan Africa: Transferable Strategies for Prevention and Care.The Lancet. Haematology. 2021. Esoh K, Wonkam-Tingang E, Wonkam A.
Interventions for Chronic Kidney Disease in People With Sickle Cell Disease.The Cochrane Database of Systematic Reviews. 2016. Roy NB, Fortin PM, Bull KR, et al.
Preoperative Blood Transfusions for Sickle Cell Disease.The Cochrane Database of Systematic Reviews. 2001. Riddington C, Williamson L.
Time-Dependent Changes in the Density and Hemoglobin F Content of Biotin-Labeled Sickle Cells.The Journal of Clinical Investigation. 1998. Franco RS, Lohmann J, Silberstein EB, et al.
Irreversibly Sickled Cells and Red Cell Survival in Sickle Cell Anemia: A Study With Both DF32P and 51CR.The American Journal of Medicine. 1978. McCurdy PR, Sherman AS.
Sickle Cell Disease.Lancet. 2026. Colombatti R, Jastaniah W, Makani J, Andemariam B.New
Health Supervision for Children and Adolescents With Sickle Cell Disease: Clinical Report.Pediatrics. 2024. Yates AM, Aygun B, Nuss R, Rogers ZR.Guideline
Evidence-Based Management of Sickle Cell Disease: Expert Panel Report, 2014.National Heart, Lung, and Blood Institute. 2013. Guideline
Low-Molecular-Weight Heparins for Managing Vaso-Occlusive Crises in People With Sickle Cell Disease.The Cochrane Database of Systematic Reviews. 2015. van Zuuren EJ, Fedorowicz Z.
Sickle Cell Disease.The New England Journal of Medicine. 2017. Piel FB, Steinberg MH, Rees DC.
Hydroxyurea (Hydroxycarbamide) for Sickle Cell Disease.The Cochrane Database of Systematic Reviews. 2022. Rankine-Mullings AE, Nevitt SJ.
Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa.The New England Journal of Medicine. 2019. Tshilolo L, Tomlinson G, Williams TN, et al.